Business Context and Reporting Period
Company: BioRestorative Therapies, Inc. (BRTX)
Filing Type: Form 8-K (Current Report)
Date of Report: February 10, 2025
Event: Regulation FD Disclosure regarding a presentation at the Orthopaedic Research Society (ORS) 2025 Annual Meeting held on February 8, 2025, in Phoenix, Arizona.
Key Financial Metrics
This filing is a disclosure of a corporate event and does not contain financial statements. The text does not provide values for revenue, profit, cash flow, margins, debt, or liquidity.
Material Changes
No material financial changes or operational updates are reported in this document. The filing solely discloses the presentation of research materials by Francisco Silva, Vice President of Research and Development.
Guidance, Outlook, and Risks
- Management Commentary: The Company intends to use the presentation materials from the ORS Annual Meeting in future presentations to investors, lenders, and other stakeholders.
- Forward-Looking Statements: The presentation materials speak as of the date of the report. The Company disclaims any obligation to update these materials to reflect future events or circumstances.
- Risks/Contingencies: The information is furnished and not "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, limiting liability exposure for the specific content of the presentation materials.
Investor Verification Checklist
- Verify the content of the Press Release (Exhibit 99.1) and Presentation Materials (Exhibit 99.2) available on the Company's website under "Scientific Publications."
- Confirm the date of the ORS Annual Meeting presentation (February 8, 2025) against the Company's official calendar.
- Review the Company's most recent 10-K or 10-Q filings for actual financial performance data, as this 8-K contains no financial metrics.